Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

40.620
-3.580-8.10%
Volume:18.78M
Turnover:777.40M
Market Cap:23.64B
PE:-9.07
High:44.500
Open:43.560
Low:40.260
Close:44.200
52wk High:80.900
52wk Low:29.980
Shares:582.00M
HK Float Shares:582.00M
Volume Ratio:1.02
T/O Rate:3.23%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-4.480
ROE:--
ROA:-11.83%
PB:6.67
PE(LYR):-9.07
PS:53.61

Loading ...

Movement Alert|INSILICO Falls 5.52% in Regular Trading, Trading at HK$40.94

Market Focus
·
Jul 30

Insilico Medicine Receives FDA Fast Track Designation for Ism6331, the Ai-Driven Pan-Tead Inhibitor, in Advanced Mesothelioma

Reuters
·
Jul 29

Insilico Medicine's Pleural Mesothelioma Drug Receives US FDA Fast Track Designation; Shares Down 4%

MT Newswires Live
·
Jul 29

Movement Alert|INSILICO Falls 5.31% in Regular Trading, ISM6331 Receives FDA Fast Track Designation But Selling Pressure Persists

Market Focus
·
Jul 29

INSILICO (03696): ISM6331 Receives FDA Fast Track Designation for Advanced Mesothelioma Treatment

Stock News
·
Jul 29

Insilico Medicine Cayman Topco - Receives FDA Fast Track Designation for Ism6331 in Advanced Mesothelioma

THOMSON REUTERS
·
Jul 29

Movement Alert|INSILICO Falls 5.07% in Regular Trading, Trading at 45.2 HKD

Market Focus
·
Jul 28

Insilico Medicine Announces Oral Presentation at Esmo 2026 for Phase 1 Clinical Study of Ism6331 in Mesothelioma and Advanced Solid Tumors

THOMSON REUTERS
·
Jul 27

INSILICO to Present First-in-Human Phase I Data for AI-Designed Pan-TEAD Inhibitor ISM6331 at ESMO 2026

Bulletin Express
·
Jul 27

Insilico Medicine Says Ism6331 Phase I Data in Mesothelioma, Advanced Solid Tumors Accepted for ESMO 2026 Rapid Oral Presentation

Reuters
·
Jul 27

Beijing's Token Economy Push and Battery Tax Shifts Reshape Market Dynamics

Stock News
·
Jul 23

INSILICO Shares Surge Over 7% Again Following Keynote at AI Conference and Major Partnership Announcements

Stock News
·
Jul 23

AI Shortens Drug Discovery to Around 1 Year in China, Insilico CEO Says

Reuters
·
Jul 23

Movement Alert|INSILICO Rises 5.46% in Regular Trading, Dense Strategic Partnerships and Sustained AI Pharma Sector Momentum

Market Focus
·
Jul 23

Movement Alert|Insilico Medicine Rises 5.47% in Regular Trading, Sector Recovery Combined with WAIC Catalyst

Market Focus
·
Jul 22

Movement Alert|Insilico Medicine Falls 5.43% in Regular Trading, Sector Pullback Compounded by Post-Lockup Investor Exit Concerns

Market Focus
·
Jul 21

Movement Alert|Insilico Medicine Rises 6.71% in Regular Trading, World AI Conference Spotlight Combines with Sector Recovery

Market Focus
·
Jul 20

Movement Alert|Insilico Medicine Falls 5.26% in Regular Trading, Trading at HK$45.22

Market Focus
·
Jul 17

AI-Powered Drug Development Accelerates Commercialization with Major Partnerships and Industry Giants Entering the Field (Related Stocks Listed)

Stock News
·
Jul 16

INSILICO releases full director roster and committee assignments

Bulletin Express
·
Jul 15